Health Care & Life Sciences » Pharmaceuticals | Assembly Biosciences Inc.

Assembly Biosciences Inc.

Assembly Biosciences Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$375.07 M
Shares Outstanding
25.55 M
Public Float
22.35 M


11711 North Meridian Street
Carmel Indiana 46032
United States
Employees -
Updated 07/08/2019
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.


View All

Derek A. Small
President, Chief Executive Officer & Director
Bill R. Ringo
Non-Executive Chairman